Nurix Therapeutics Inc (NRIX)
Healthcare
Biotechnology
23.20 $
+0.0%
vs. previous close
Closing price · As of: 3. Aug 2026
Nurix Therapeutics Inc (NRIX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -97 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -41 | 27 | -42 | -40 | -42 | -49 | -61 | -63 | -57 | -68 | -72 | -97 | -294 | |
| 3.4 | 3.8 | 3.9 | 4.1 | 4.1 | 4.3 | 4.1 | 5.1 | 5.0 | 4.6 | 3.8 | 3.9 | 17 | |
| 8.4 | 8.0 | 7.8 | 8.8 | 8.8 | 8.5 | 8.7 | 10 | 9.8 | 9.1 | 9.4 | 11 | 40 | |
| 7.2 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -15 | 54 | -10 | -5.9 | -2.7 | 0.4 | -14 | -32 | 16 | -1.6 | 3.9 | -3.9 | 15 | |
| 2.5 | 2.6 | 2.9 | 1.9 | 2.3 | 2.1 | 3.5 | 2.7 | 2.7 | 5.1 | 1.0 | 1.9 | 11 | |
| 23 | -14 | 36 | -131 | -21 | -141 | 26 | 71 | 50 | 0.3 | -124 | 93 | 20 | |
| – | – | – | 0.0 | 0.0 | – | – | 1.3 | 2.2 | – | 1.6 | – | – | |
| 1.7 | 0.0 | 1.6 | 238 | 46 | 201 | 1.5 | 0.0 | 1.2 | 236 | 20 | 0.1 | 257 | |
| -17 | 12 | -4.8 | 67 | -18 | 11 | -34 | 8.3 | -5.8 | 169 | -176 | -3.5 | -17 | |
| -44 | 24 | -45 | -42 | -45 | -51 | -65 | -66 | -60 | -73 | -73 | -99 | -305 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.